Infectious prion diseases in humans: Cannibalism, iatrogenicity and zoonoses

Infection, Genetics and Evolution

Volumn 26, Issue , 2014, Pages 303-312

  Haïk, Stéphane ^a,b,c   Brandel, Jean Philippe ^a,b,c  

^a INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c Centre National de Référence des Agents Transmissibles Non Conventionnels   (France)

Author keywords

Creutzfeldt Jakob disease; Infectious forms; Kuru; Prion diseases; Prion strains

Indexed keywords

GONADOTROPIN; HUMAN GROWTH HORMONE; PRION PROTEIN; PRION;

ABNORMAL BEHAVIOR; AMYLOID PLAQUE; ASYMPTOMATIC INFECTION; BLOOD TRANSFUSION; BOVINE SPONGIFORM ENCEPHALOPATHY; BRAIN GRAFT; CANNIBALISM; CEREBELLAR ATAXIA; CORNEA TRANSPLANTATION; CREUTZFELDT JAKOB DISEASE; DEMENTIA; DISEASE DURATION; DISEASE TRANSMISSION; DRUG CONTAMINATION; DURA MATER; EPIDEMIC; FOOD CONTAMINATION; HETEROZYGOTE; HOMOZYGOTE; HOST SUSCEPTIBILITY; HUMAN; IATROGENIC CREUTZFELDT JAKOB DISEASE; IATROGENIC DISEASE; INCUBATION TIME; KURU; MISSENSE MUTATION; NONHUMAN; PRION DISEASE; PRION PROTEIN GENE; PRIORITY JOURNAL; REVIEW; SCRAPIE; SINGLE NUCLEOTIDE POLYMORPHISM; SPORADIC CREUTZFELDT JAKOB DISEASE; VARIANT CREUTZFELDT JAKOB DISEASE; ZOONOSIS; ANIMAL; GENETICS; METABOLISM; PRION; PRION DISEASES; TRANSMISSION;

ANIMALS; CANNIBALISM; HUMANS; IATROGENIC DISEASE; PRION DISEASES; PRIONS; ZOONOSES;

EID: 84903839048     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2014.06.010     Document Type: Review

References (140)

1. Alpers M.P. Review. The epidemiology of kuru: monitoring the epidemic from its peak to its end. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2008, 363:3707-3713.
2. Asante E.A., Linehan J.M., Gowland I., Joiner S., Fox K., Cooper S., Osiguwa O., Gorry M., Welch J., Houghton R., Desbruslais M., Brandner S., Wadsworth J.D., Collinge J. Dissociation of pathological and molecular phenotype of variant Creutzfeldt-Jakob disease in transgenic human prion protein 129 heterozygous mice. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:10759-10764.
3. Bate C., Tayebi M., Williams A. The glycosylphosphatidylinositol anchor is a major determinant of prion binding and replication. Biochem. J. 2010, 428:95-101.
4. Ben-Zaken O., Tzaban S., Tal Y., Horonchik L., Esko J.D., Vlodavsky I., Taraboulos A. Cellular heparan sulfate participates in the metabolism of prions. J. Biol. Chem. 2003, 278:40041-40049.
5. Beringue V., Herzog L., Jaumain E., Reine F., Sibille P., Le Dur A., Vilotte J.L., Laude H. Facilitated cross-species transmission of prions in extraneural tissue. Science 2012, 335:472-475.
6. Beringue V., Herzog L., Reine F., Le Dur A., Casalone C., Vilotte J.L., Laude H. Transmission of atypical bovine prions to mice transgenic for human prion protein. Emerg. Infect. Dis. 2008, 14:1898-1901.
7. Beringue V., Le Dur A., Tixador P., Reine F., Lepourry L., Perret-Liaudet A., Haik S., Vilotte J.L., Fontes M., Laude H. Prominent and persistent extraneural infection in human PrP transgenic mice infected with variant CJD. PLoS ONE 2008, 3:e1419.
8. Bernoulli C., Siegfried J., Baumgartner G., Regli F., Rabinowicz T., Gajdusek D.C., Gibbs C.J. Danger of accidental person-to-person transmission of Creutzfeldt-Jakob disease by surgery. Lancet 1977, 1:478-479.
9. Bessen R.A., Kocisko D.A., Raymond G.J., Nandan S., Lansbury P.T., Caughey B. Non-genetic propagation of strain-specific properties of scrapie prion protein. Nature 1995, 375:698-700.
10. Billette de Villemeur T., Deslys J.P., Pradel A., Soubri C., Alpérovitch A., Tardieu M., Chaussain J.L., Hauw J.J., Dormont D., Ruberg M., Agid Y. Creutzfeldt-Jakob disease from contaminated growth hormone extracts in France. Neurology 1996, 47:690-695.
11. Billette de Villemeur T., Gelot A., Deslys J.P., Dormont D., Duyckaerts C., Jardin L., Denni J., Robain O. Iatrogenic Creutzfeldt-Jakob disease in three growth hormone recipients: a neuropathological study. Neuropathol. Appl. Neurobiol. 1994, 20:111-117.
12. Bishop M.T., Hart P., Aitchison L., Baybutt H.N., Plinston C., Thomson V., Tuzi N.L., Head M.W., Ironside J.W., Will R.G., Manson J.C. Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol. 2006, 5:393-398.
13. Bishop M.T., Kovacs G.G., Sanchez-Juan P., Knight R.S. Cathepsin D SNP associated with increased risk of variant Creutzfeldt-Jakob disease. BMC Med. Genet. 2008, 9:31.
14. Bishop M.T., Pennington C., Heath C.A., Will R.G., Knight R.S. PRNP variation in UK sporadic and variant Creutzfeldt Jakob disease highlights genetic risk factors and a novel non-synonymous polymorphism. BMC Med. Genet. 2009, 10:146.
15. Bishop M.T., Sanchez-Juan P., Knight R.S. Splice site SNPs of phospholipase PLCXD3 are significantly associated with variant and sporadic Creutzfeldt-Jakob disease. BMC Med. Genet. 2013, 14:91.
16. Bishop M.T., Will R.G., Manson J.C. Defining sporadic Creutzfeldt-Jakob disease strains and their transmission properties. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:12005-12010.
17. Brandel J.P., Galanaud D., Freeman L., Laplanche J.L., Haik S. Variant or sporadic Creutzfeldt-Jakob disease?. Lancet 2010, 375:889. author reply 889-890.
18. Brandel J.P., Heath C.A., Head M.W., Levavasseur E., Knight R., Laplanche J.L., Langeveld J.P., Ironside J.W., Hauw J.J., Mackenzie J., Alperovitch A., Will R.G., Haik S. Variant Creutzfeldt-Jakob disease in France and the United Kingdom: evidence for the same agent strain. Ann. Neurol. 2009, 65:249-256.
19. Brandel J.P., Peoc'h K., Beaudry P., Welaratne A., Bottos C., Agid Y., Laplanche J.L. 14-3-3 protein cerebrospinal fluid detection in human growth hormone-treated Creutzfeldt-Jakob disease patients. Ann. Neurol. 2001, 49:257-260.
20. Brandel J.P., Preece M., Brown P., Croes E., Laplanche J.L., Agid Y., Will R., Alperovitch A. Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UK. Lancet 2003, 362:128-130.
21. Brandner S., Whitfield J., Boone K., Puwa A., O'Malley C., Linehan J.M., Joiner S., Scaravilli F., Calder I.M.P.A., Wadsworth J.D., Collinge J. Central and peripheral pathology of kuru: pathological analysis of a recent case and comparison with other forms of human prion disease. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2008, 363:3755-3763.
22. Brown P., Brandel J.P., Preece M., Sato T. Iatrogenic Creutzfeldt-Jakob disease: the waning of an era. Neurology 2006, 67:389-393.
23. Brown P., Brandel J.P., Sato T., Nakamura Y., MacKenzie J., Will R.G., Ladogana A., Pocchiari M., Leschek E.W., Schonberger L.B. Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerg. Infect. Dis. 2012, 18:901-907.
24. Bruce M.E., Dickinson A.G., Fraser H. Cerebral amyloidosis in scrapie in the mouse: effect of agent strain and mouse genotype. Neuropathol. Appl. Neurobiol. 1976, 2:471-478.
25. Bruce M.E., Will R.G., Ironside J.W., McConnell I., Drummond D., Suttie A., McCardle L., Chree A., Hope J., Birkett C., Cousens S., Fraser H., Bostock C.J. Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 1997, 389:498-501.
26. Bucalossi C., Cosseddu G., D'Agostino C., Di Bari M.A., Chiappini B., Conte M., Rosone F., De Grossi L., Scavia G., Agrimi U., Nonno R., Vaccari G. Assessment of the genetic susceptibility of sheep to scrapie by protein misfolding cyclic amplification and comparison with experimental scrapie transmission studies. J. Virol. 2011, 85:8386-8392.
27. Casalone C., Zanusso G., Acutis P., Ferrari S., Capucci L., Tagliavini F., Monaco S., Caramelli M. Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:3065-3070.
28. Castilla J., Morales R., Saa P., Barria M., Gambetti P., Soto C. Cell-free propagation of prion strains. EMBO J. 2008, 27:2557-2566.
29. Caughey B., Brown K., Raymond G.J., Katenstein G.E., Thresher W. Binding of the protease-sensitive form of prion protein PrP to sulfated glycosaminoglycan and Congo red. J. Virol. 1994, 68:2135-2141.
30. Caughey B., Raymond G.J., Bessen R.A. Strain-dependent differences in beta-sheet conformations of abnormal prion protein. J. Biol. Chem. 1998, 27:32230-32235.
31. Cervenakova L., Goldfarb L.G., Garruto R., Lee H.S., Gajdusek D.C., Brown P. Phenotype-genotype studies in kuru: implications for new variant Creutzfeldt-Jakob disease. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:13239-13241.
32. Chadeau-Hyam M., Alperovitch A. Risk of variant Creutzfeldt-Jakob disease in France. Int. J. Epidemiol. 2005, 34:46-52.
33. Chazot G., Broussolle E., Lapras C., Blattler T., Aguzzi A., Kopp N. New variant of Creutzfeldt-Jakob disease in a 26-year-old French man. Lancet 1996, 347:1181.
34. Collinge J. Medicine. Prion strain mutation and selection. Science 2010, 328:1111-1112.
35. Collinge J., Sidle K.C.L., Meads J., Ironside J., Hill A.F. Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD. Nature 1996, 383:685-690.
36. Collinge J., Whitfield J., McKintosh E., Beck J., Mead S., Thomas D.J., Alpers M.P. Kuru in the 21st century - an acquired human prion disease with very long incubation periods. Lancet 2006, 367:2068-2074.
37. Collinge J., Whitfield J., McKintosh E., Frosh A., Mead S., Hill A.F., Brandner S., Thomas D., Alpers M.P. A clinical study of kuru patients with long incubation periods at the end of the epidemic in Papua New Guinea. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2008, 363:3725-3739.
38. Comoy E.E., Casalone C., Lescoutra-Etchegaray N., Zanusso G., Freire S., Marce D., Auvre F., Ruchoux M.M., Ferrari S., Monaco S., Sales N., Caramelli M., Leboulch P., Brown P., Lasmezas C.I., Deslys J.P. Atypical BSE (BASE) transmitted from asymptomatic aging cattle to a primate. PLoS ONE 2008, 3:e3017.
39. DeArmond S.J., Sanchez H., Yehiely F., Qiu Y., NinchakCasey A., Daggett V., Camerino A.P., Cayetano J., Rogers M., Groth D., Torchia M., Tremblay P., Scott M.R., Cohen F.E., Prusiner S.B. Selective neuronal targeting in prion disease. Neuron 1997, 19:1337-1348.
40. Diack A.B., Ritchie D., Bishop M., Pinion V., Brandel J.P., Haik S., Tagliavini F., Van Duijn C., Belay E.D., Gambetti P., Schonberger L.B., Piccardo P., Will R.G., Manson J.C. Constant transmission properties of variant Creutzfeldt-Jakob disease in 5 countries. Emerg. Infect. Dis. 2012, 18:1574-1579.
41. Duffy I., Wolf J., Colins G., DeVoe A.G., Streeten B., Cowen D. Possible person-to-person transmission of Creutzfeldt-Jakob disease. N. Engl. J. Med. 1974, 290:692-693.
42. el Hachimi K.H., Chaunu M.P., Cervenakova L., Brown P., Foncin J.F. Putative neurosurgical transmission of Creutzfeldt-Jakob disease with analysis of donor and recipient: agent strains. C. R. Acad. Sci. III 1997, 320:319-328.
43. Gajdusek D.C., Gibbs C.J. Transmission of the two subacute spongiform encephalopathies of man (kuru and Creutzfeldt-Jakob disease) to New World monkeys. Nature 1971, 230:588-591.
44. Gajdusek D.C., Gibbs C.J., Alpers M.P. Experimental transmission of a kuru-like syndrome in chimpanzees. Nature 1966, 209:794-796.
45. Gajdusek D.C., Gibbs C.J. Transmission of kuru from man to rhesus monkey (Macaca mulatta) 8 and one-half years after inoculation. Nature 1972, 240:351.
46. Gajdusek D.C., Zigas V. Degenerative disease of the central nervous system in New Guinea: the endemic occurrence of "kuru" in the native population. N. Engl. J. Med. 1957, 257:974-978.
47. Garcia J.A., Zhang D., Estill S.J., Michnoff C., Rutter J., Reick M., Scott K., Diaz-Arrastia R., McKnight S.L. Impaired cued and contextual memory in NPAS2-deficient mice. Science 2000, 288:2226-2230.
48. Gauczynski S., Peyrin J.M., Haik S., Leucht C., Hundt C., Rieger R., Krasemann S., Deslys J.P., Dormont D., Lasmezas C.I., Weiss S. The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein. EMBO J. 2001, 20:5863-5875.
49. Gibbs C.J., Gajdusek D.C., Asher D.M., Alpers M.P., Beck E., Daniel P.M., Matthews W.B. Creutzfeldt-Jakob disease (spongiform encephalopathy): transmission to the chimpanzee. Science 1968, 161:388-389.
50. Gibbs C.J., Asher D.M., Kobrine A., Amyx H.L., Sulima M.P., Gajdusek D.C. Transmission of Creutzfeldt-Jakob disease to a chimpanzee by electrodes contaminated during neurosurgery. J. Neurol. Neurosurg. Psychiatry 1994, 57:757-758.
51. Giles K., Glidden D.V., Patel S., Korth C., Groth D., Lemus A., DeArmond S.J., Prusiner S.B. Human prion strain selection in transgenic mice. Ann. Neurol. 2010, 68:151-161.
52. Gill O.N., Spencer Y., Richard-Loendt A., Kelly C., Dabaghian R., Boyes L., Linehan J., Simmons M., Webb P., Bellerby P., Andrews N., Hilton D.A., Ironside J.W., Beck J., Poulter M., Mead S., Brandner S. Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey. BMJ 2013, 347:f5675.
53. Hadlow W.J. Scrapie and kuru. Lancet 1959, 2:289-290.
54. Haik S., Brandel J.P. Biochemical and strain properties of CJD prions: complexity versus simplicity. J. Neurochem. 2011, 119:251-261.
55. Haik S., Brandel J.P., Oppenheim C., Sazdovitch V., Dormont D., Hauw J., Marsault C. Sporadic CJD clinically mimicking variant CJD with bilateral increased signal in the pulvinar. Neurology 2002, 58:148-149.
56. Haïk S., Faucheux B.A., Hauw J.J. Brain targeting through the autonomous nervous system: lessons from prion diseases. Trends Mol. Med. 2004, 10:107-112.
57. Haik S., Faucheux B.A., Sazdovitch V., Privat N., Kemeny J.L., Perret-Liaudet A., Hauw J.J. The sympathetic nervous system is involved in variant Creutzfeldt-Jakob disease. Nat. Med. 2003, 9:1121-1123.
58. Haik S., Peoc'h K., Brandel J.P., Privat N., Laplanche J.L., Faucheux B.A., Hauw J.J. Striking PrPsc heterogeneity in inherited prion diseases with the D178N mutation. Ann. Neurol. 2004, 56:909-910.
59. Hainfellner J.A., Liberski P.P., Guiroy D.C., Cervenakova L., Brown P., Gajdusek D.C., Budka H. Pathology and immunocytochemistry of a Kuru Brain. Brain Pathol. 1997, 7:547-553.
60. Hamaguchi T., Sakai K., Noguchi-Shinohara M., Nozaki I., Takumi I., Sanjo N., Sadakane A., Nakamura Y., Kitamoto T., Saito N., Mizusawa H., Yamada M. Insight into the frequent occurrence of dura mater graft-associated Creutzfeldt-Jakob disease in Japan. J. Neurol. Neurosurg. Psychiatry 2013, 84:1171-1175.
61. Hannaoui S., Gougerot A., Privat N., Levavasseur E., Bizat N., Hauw J.J., Brandel J.P., Haik S. Cycline efficacy on the propagation of human prions in primary cultured neurons is strain-specific. J. Infect. Dis. 2014, 209:1144-1148.
62. Hannaoui S., Maatouk L., Privat N., Levavasseur E., Faucheux B.A., Haik S. Prion propagation and toxicity occur in vitro with two-phase kinetics specific to strain and neuronal type. J. Virol. 2013, 87:2535-2548.
63. Head M.W., Bunn T.J., Bishop M.T., McLoughlin V., Lowrie S., McKimmie C.S., Williams M.C., McCardle L., MacKenzie J., Knight R., Will R.G., Ironside J.W. Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991-2002. Ann. Neurol. 2004, 55:851-859.
64. Heckmann J.G., Lang C.J., Petruch F., Druschky A., Erb C., Brown P., Neundorfer B. Transmission of Creutzfeldt-Jakob disease via a corneal transplant. J. Neurol. Neurosurg. Psychiatry 1997, 63:388-390.
65. Hill A.F., Desbruslais M., Joiner S., Sidle K.C.L., Gowland I., Collinge J., Doey L.J., Lantos P. The same prion strain causes vCJD and BSE. Nature 1997, 389:448-450.
66. Hill A.F., Zeidler M., Ironside J., Collinge J. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 1997, 349:99-100.
67. Hilton D.A., Fathers E., Edwards P., Ironside J.W., Zajicek J. Prion immunoreactivity in appendix before clinical onset of variant Creutzfeldt-Jakob disease. Lancet 1998, 352:703-704.
68. Hundt C., Peyrin J.M., Haik S., Gauczynski S., Leucht C., Rieger R., Riley M.L., Deslys J.P., Dormont D., Lasmezas C.I., Weiss S. Identification of interaction domains of the prion protein with its 37-kDa/67-kDa laminin receptor. EMBO J. 2001, 20:5876-5886.
69. Ironside J.W. New variant Creutzfeldt-Jakob disease in the UK: clinical and pathological studies. Brain Pathol. 1997, 7:1243-1245.
70. Jones M., Peden A.H., Prowse C.V., Groner A., Manson J.C., Turner M.L., Ironside J.W., MacGregor I.R., Head M.W. In vitro amplification and detection of variant Creutzfeldt-Jakob disease PrPSc. J. Pathol. 2007, 213:21-26.
71. Jones M., Wight D., Barron R., Jeffrey M., Manson J., Prowse C., Ironside J.W., Head M.W. Molecular model of prion transmission to humans. Emerg. Infect. Dis. 2009, 15:2013-2016.
72. Kaneko K., Zulianello L., Scott M., Cooper C.M., Wallace A.C., James T.L., Cohen F.E., Prusiner S.B. Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagation. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:10069-10074.
73. Kaski D., Mead S., Hyare H., Cooper S., Jampana R., Overell J., Knight R., Collinge J., Rudge P. Variant CJD in an individual heterozygous for PRNP codon 129. Lancet 2009, 374:2128.
74. Kim J.I., Surewicz K., Gambetti P., Surewicz W.K. The role of glycophosphatidylinositol anchor in the amplification of the scrapie isoform of prion protein in vitro. FEBS Lett. 2009, 583:3671-3675.
75. Kobayashi A., Asano M., Mohri S., Kitamoto T. Cross-sequence transmission of sporadic Creutzfeldt-Jakob disease creates a new prion strain. J. Biol. Chem. 2007, 282:30022-30028.
76. Kong Q., Huang S., Zou W., Vanegas D., Wang M., Wu D., Yuan J., Zheng M., Bai H., Deng H., Chen K., Jenny A.L., O'Rourke K., Belay E.D., Schonberger L.B., Petersen R.B., Sy M.S., Chen S.G., Gambetti P. Chronic wasting disease of elk: transmissibility to humans examined by transgenic mouse models. J. Neurosci. 2005, 25:7944-7949.
77. Kong Q., Zheng M., Casalone C., Qing L., Huang S., Chakraborty B., Wang P., Chen F., Cali I., Corona C., Martucci F., Iulini B., Acutis P., Wang L., Liang J., Wang M., Li X., Monaco S., Zanusso G., Zou W.Q., Caramelli M., Gambetti P. Evaluation of the human transmission risk of an atypical bovine spongiform encephalopathy prion strain. J. Virol. 2008, 82:3697-3701.
78. Kopp N., Streichenberger N., Deslys J.P., Laplanche J.L., Chazot G. Creutzfeldt-Jakob disease in a 52-year-old woman with florid plaques. Lancet 1996, 348:1239-1240.
79. Kovacs G.G., Puopolo M., Ladogana A., Pocchiari M., Budka H., van Duijn C., Collins S.J., Boyd A., Giulivi A., Coulthart M., Delasnerie-Laupretre N., Brandel J.P., Zerr I., Kretzschmar H.A., de Pedro-Cuesta J., Calero-Lara M., Glatzel M., Aguzzi A., Bishop M., Knight R., Belay G., Will R., Mitrova E. Genetic prion disease: the EUROCJD experience. Hum. Genet. 2005, 118:166-174.
80. Kretzschmar H.A., Sethi S., Foldvari Z., Windl O., Querner V., Zerr I., Poser S. Latrogenic Creutzfeldt-Jakob disease with florid plaques. Brain Pathol. 2003, 13:245-249.
81. Kretzschmar H.A., Stowring L.E., Westaway D., Stubblebine W.H., Prusiner S.B., DeArmond S.J. Molecular cloning of a human prion protein cDNA. DNA 1986, 5:315-324.
82. Langevin C., Andreoletti O., Le Dur A., Laude H., Beringue V. Marked influence of the route of infection on prion strain apparent phenotype in a scrapie transgenic mouse model. Neurobiol. Dis. 2011, 41:219-225.
83. Lasmézas C.I., Deslys J.P., Demaimay R., Adjou K.T., Lamoury F., Dormont D., Robain O., Ironside J., Hauw J.J. BSE transmission to macaques. Nature 1996, 381:743-744.
84. Lee H.S., Brown P., Cervenakova L., Garruto R.M., Alpers M.P., Gajdusek D.C., Goldfarb L.G. Increased susceptibility to Kuru of carriers of the PRNP 129 methionine/methionine genotype. J. Infect. Dis. 2001, 183:192-196.
85. Leucht C., Simoneau S., Rey C., Vana K., Rieger R., Lasmezas C.I., Weiss S. The 37kDa/67kDa laminin receptor is required for PrP(Sc) propagation in scrapie-infected neuronal cells. EMBO Rep. 2003, 4:290-295.
86. Levavasseur E., Laffont-Proust I., Morain E., Faucheux B.A., Privat N., Peoc'h K., Sazdovitch V., Brandel J.P., Hauw J.J., Haik S. Regulating factors of PrP glycosylation in Creutzfeldt-Jakob disease - implications for the dissemination and the diagnosis of human prion strains. PLoS ONE 2008, 3:e2786.
87. Liberski P.P., Sikorska B., Lindenbaum S., Goldfarb L.G., McLean C., Hainfellner J.A., Brown P. Kuru: genes, cannibals and neuropathology. J. Neuropathol. Exp. Neurol. 2012, 71:92-103.
88. Llewelyn C.A., Hewitt P.E., Knight R.S., Amar K., Cousens S., Mackenzie J., Will R.G. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004, 363:417-421.
89. Lloyd S.E., Maytham E.G., Pota H., Grizenkova J., Molou E., Uphill J., Hummerich H., Whitfield J., Alpers M.P., Mead S., Collinge J. HECTD2 is associated with susceptibility to mouse and human prion disease. PLoS Genet. 2009, 5:e1000383.
90. Lloyd S.E., Mead S., Collinge J. Genetics of prion diseases. Curr. Opin. Genet. Dev. 2013, 23:345-351.
91. McLean C.A., Ironside J.W., Alpers M.P., Brown P.W., Cervenakova L., Anderson R., Masters C.L. Comparative neuropathology of kuru with the new variant of Creutzfeldt-Jakob disease: evidence for strain of agent predominating over genotype of host. Brain Pathol. 1998, 8:429-437.
92. Mead S., Stumpf M.P., Whitfield J., Beck J.A., Poulter M., Campbell T., Uphill J.B., Goldstein D., Alpers M., Fisher E.M., Collinge J. Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science 2003, 300:640-643.
93. Mead S., Uphill J., Beck J., Poulter M., Campbell T., Lowe J., Adamson G., Hummerich H., Klopp N., Ruckert I.M., Wichmann H.E., Azazi D., Plagnol V., Pako W.H., Whitfield J., Alpers M.P., Whittaker J., Balding D.J., Zerr I., Kretzschmar H., Collinge J. Genome-wide association study in multiple human prion diseases suggests genetic risk factors additional to PRNP. Hum. Mol. Genet. 2012, 21:1897-1906.
94. Mead S., Whitfield J., Poulter M., Shah P., Uphill J., Beck J., Campbell T., Al-Dujaily H., Hummerich H., Alpers M.P., Collinge J. Genetic susceptibility, evolution and the kuru epidemic. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2008, 363:3741-3746.
95. Mead S., Whitfield J., Poulter M., Shah P., Uphill J., Campbell T., Al-Dujaily H., Hummerich H., Beck J., Mein C.A., Verzilli C., Whittaker J., Alpers M.P., Collinge J. A novel protective prion protein variant that colocalizes with kuru exposure. N. Engl. J. Med. 2009, 361:2056-2065.
96. Morales R., Abid K., Soto C. The prion strain phenomenon: molecular basis and unprecedented features. Biochim. Biophys. Acta 2007, 1772:681-691.
97. Moser M., Colello R.J., Pott U., Oesch B. Developmental expression of the prion protein gene in glial cells. Neuron 1995, 14:509-517.
98. Nicholas B., Rudrasingham V., Nash S., Kirov G., Owen M.J., Wimpory D.C. Association of Per1 and Npas2 with autistic disorder: support for the clock genes/social timing hypothesis. Mol. Psychiatry 2007, 12:581-592.
99. Noguchi-Shinohara M., Hamaguchi T., Kitamoto T., Sato T., Nakamura Y., Mizusawa H., Yamada M. Clinical features and diagnosis of dura mater graft associated Creutzfeldt Jakob disease. Neurology 2007, 69:360-367.
100. Nozaki I., Hamaguchi T., Sanjo N., Noguchi-Shinohara M., Sakai K., Nakamura Y., Sato T., Kitamoto T., Mizusawa H., Moriwaka F., Shiga Y., Kuroiwa Y., Nishizawa M., Kuzuhara S., Inuzuka T., Takeda M., Kuroda S., Abe K., Murai H., Murayama S., Tateishi J., Takumi I., Shirabe S., Harada M., Sadakane A., Yamada M. Prospective 10-year surveillance of human prion diseases in Japan. Brain 2010, 133:3043-3057.
101. Parchi P., Cescatti M., Notari S., Schulz-Schaeffer W.J., Capellari S., Giese A., Zou W.Q., Kretzschmar H., Ghetti B., Brown P. Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease. Brain 2010, 133:3030-3042.
102. Parchi P., Giese A., Capellari S., Brown P., Schulz-Schaeffer W., Windl O., Zerr I., Budka H., Kopp N., Piccardo P., Poser S., Rojiani A., Streichemberger N., Julien J., Vital C., Ghetti B., Gambetti P., Kretzschmar H. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann. Neurol. 1999, 46:224-233.
103. Parchi P., Notari S., Weber P., Schimmel H., Budka H., Ferrer I., Haik S., Hauw J.J., Head M.W., Ironside J.W., Limido L., Rodriguez A., Strobel T., Tagliavini F., Kretzschmar H.A. Inter-laboratory assessment of PrPSc typing in Creutzfeldt-Jakob disease: a Western blot study within the NeuroPrion Consortium. Brain Pathol. 2009, 19:384-391.
104. Partonen T. Clock gene variants in mood and anxiety disorders. J. Neural. Transm. 2012, 119:1133-1145.
105. Peden A.H., Head M.W., Ritchie D.L., Bell J.E., Ironside J.W. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 2004, 364:527-529.
106. Peoc'h K., Levavasseur E., Delmont E., De Simone A., Laffont-Proust I., Privat N., Chebaro Y., Chapuis C., Bedoucha P., Brandel J.P., Laquerriere A., Kemeny J.L., Hauw J.J., Borg M., Rezaei H., Derreumaux P., Laplanche J.L., Haik S. Substitutions at residue 211 in the prion protein drive a switch between CJD and GSS syndrome, a new mechanism governing inherited neurodegenerative disorders. Hum. Mol. Genet. 2012, 21:5417-5428.
107. Peterson D.A., Wolfe L.G., Deinhardt F., Gajdusek D.C., Gibbs C.J. Transmission of kuru and Creutzfeldt-Jakob disease to marmoset monkeys. Intervirology 1974, 2:14-19.
108. Priola S.A., McNally K.L. The role of the prion protein membrane anchor in prion infection. Prion 2009, 3:134-138.
109. Prusiner S.B. Novel proteinaceous infectious particles cause scrapie. Science 1982, 216:136-144.
110. Prusiner S.B. Prions. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:13363-13383.
111. Puoti G., Giaccone G., Rossi G., Canciani B., Bugiani O., Tagliavini F. Sporadic Creutzfeldt-Jakob disease: co-occurrence of different types of PrP(Sc) in the same brain. Neurology 1999, 53:2173-2176.
112. Race B., Meade-White K.D., Phillips K., Striebel J., Race R., Chesebro B. Chronic wasting disease agents in nonhuman primates. Emerg. Infect. Dis. 2014, 20:833-837.
113. Sanchez-Juan P., Bishop M.T., Aulchenko Y.S., Brandel J.P., Rivadeneira F., Struchalin M., Lambert J.C., Amouyel P., Combarros O., Sainz J., Carracedo A., Uitterlinden A.G., Hofman A., Zerr I., Kretzschmar H.A., Laplanche J.L., Knight R.S., Will R.G., van Duijn C.M. Genome-wide study links MTMR7 gene to variant Creutzfeldt-Jakob risk. Neurobiol. Aging 2012, 33(1487):e1421-e1488.
114. Sanchez-Juan P., Cousens S.N., Will R.G., van Duijn C.M. Source of variant Creutzfeldt-Jakob disease outside United Kingdom. Emerg. Infect. Dis. 2007, 13:1166-1169.
115. Sekercioglu C.H. Prion diseases and a penchant for brains. Science 2004, 305:342-343.
116. Siepka S.M., Yoo S.H., Park J., Lee C., Takahashi J.S. Genetics and neurobiology of circadian clocks in mammals. Cold Spring Harb. Symp. Quant. Biol. 2007, 72:251-259.
117. Sim V.L., Caughey B. Ultrastructures and strain comparison of under-glycosylated scrapie prion fibrils. Neurobiol. Aging 2009, 30:2031-2042.
118. Supattapone S. Elucidating the role of cofactors in mammalian prion propagation. Prion 2013, 8:100-105.
119. Tamguney G., Giles K., Bouzamondo-Bernstein E., Bosque P.J., Miller M.W., Safar J., DeArmond S.J., Prusiner S.B. Transmission of elk and deer prions to transgenic mice. J. Virol. 2006, 80:9104-9114.
120. Telling G.C., Parchi P., Dearmond S.J., Cortelli P., Montagna P., Gabizon R., Mastrianni J., Lugaresi E., Gambetti P., Prusiner S.B. Evidence for the conformation of the pathologic isoform of the prion protein enciphering and propagating prion diversity. Science 1996, 274:2079-2082.
121. Telling G.C., Scott M., Mastrianni J., Gabizon R., Torchia M., Cohen F.E., DeArmond S.J., Prusiner S.B. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 1995, 83:79-90.
122. Thomzig A., Spassov S., Friedrich M., Naumann D., Beekes M. Discriminating scrapie and bovine spongiform encephalopathy isolates by infrared spectroscopy of pathological prion protein. J. Biol. Chem. 2004, 279:33847-33854.
123. Tixador P., Herzog L., Reine F., Jaumain E., Chapuis J., Le Dur A., Laude H., Beringue V. The physical relationship between infectivity and prion protein aggregates is strain-dependent. PLoS Pathog. 2010, 6:e1000859.
124. Uro-Coste E., Cassard H., Simon S., Lugan S., Bilheude J.M., Perret-Liaudet A., Ironside J.W., Haik S., Basset-Leobon C., Lacroux C., Peoch K., Streichenberger N., Langeveld J., Head M.W., Grassi J., Hauw J.J., Schelcher F., Delisle M.B., Andreoletti O. Beyond PrP9res type 1/type 2 dichotomy in Creutzfeldt-Jakob disease. PLoS Pathog. 2008, 4:e1000029.
125. Wadsworth J.D., Asante E.A., Desbruslais M., Linehan J.M., Joiner S., Gowland I., Welch J., Stone L., Lloyd S.E., Hill A.F., Brandner S., Collinge J. Human prion protein with valine 129 prevents expression of variant CJD phenotype. Science 2004, 306:1793-1796.
126. Wadsworth J.D., Joiner S., Linehan J.M., Balkema-Buschmann A., Spiropoulos J., Simmons M.M., Griffiths P.C., Groschup M.H., Hope J., Brandner S., Asante E.A., Collinge J. Atypical scrapie prions from sheep and lack of disease in transgenic mice overexpressing human prion protein. Emerg. Infect. Dis. 2013, 19:1731-1739.
127. Wadsworth J.D., Joiner S., Linehan J.M., Desbruslais M., Fox K., Cooper S., Cronier S., Asante E.A., Mead S., Brandner S., Hill A.F., Collinge J. Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:3885-3890.
128. Weissmann C. The state of the prion. Nat. Rev. Microbiol. 2004, 2:861-871.
129. Whitfield J.T., Pako W.H., Collinge J., Alpers M.P. Mortuary rites of the South Fore and kuru. Philos. Trans. R. Soc. Lond. B Biol. Sci. 2008, 363:3721-3724.
130. Will R.G. Acquired prion disease: iatrogenic CJD, variant CJD, kuru. Br. Med. Bull. 2003, 66:255-265.
131. Will R.G., Ironside J.W., Zeidler M., Cousens S.N., Estibeiro K., Alperovitch A., Poser S., Pocchiari M., Hofman A., Smith P.G. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996, 347:921-925.
132. Will R.G., Matthews W.B. Evidence for case-to-case transmission of Creutzfeldt-Jakob disease. J. Neurol. Neurosurg. Psychiatry 1982, 45:235-238.
133. Wilson R., Plinston C., Hunter N., Casalone C., Corona C., Tagliavini F., Suardi S., Ruggerone M., Moda F., Graziano S., Sbriccoli M., Cardone F., Pocchiari M., Ingrosso L., Baron T., Richt J., Andreoletti O., Simmons M., Lockey R., Manson J.C., Barron R.M. Chronic wasting disease and atypical forms of bovine spongiform encephalopathy and scrapie are not transmissible to mice expressing wild-type levels of human prion protein. J. Gen. Virol. 2012, 93:1624-1629.
134. Wong C., Xiong L.W., Horiuchi M., Raymond L., Wehrly K., Chesebro B., Caughey B. Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein. EMBO J. 2001, 20:377-386.
135. Wroe S.J., Pal S., Siddique D., Hyare H., Macfarlane R., Joiner S., Linehan J.M., Brandner S., Wadsworth J.D., Hewitt P., Collinge J. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet 2006, 368:2061-2067.
136. Yamada M., Noguchi-Shinohara M., Hamaguchi T., Nozaki I., Kitamoto T., Sato T., Nakamura Y., Mizusawa H. Dura mater graft-associated Creutzfeldt-Jakob disease in Japan: clinicopathological and molecular characterization of the two distinct subtypes. Neuropathology 2009, 29:609-618.
137. Yull H.M., Ritchie D.L., Langeveld J.P., van Zijderveld F.G., Bruce M.E., Ironside J.W., Head M.W. Detection of type 1 prion protein in variant Creutzfeldt-Jakob disease. Am. J. Pathol. 2006, 168:151-157.
138. Zahn R., Liu A., Luhrs T., Riek R., von Schroetter C., Lopez Garcia F., Billeter M., Calzolai L., Wider G., Wuthrich K. NMR solution structure of the human prion protein. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:145-150.
139. Zeidler M., Sellar R.J., Collie D.A., Knight R., Stewart G., Macleod M.A., Ironside J.W., Cousens S., Colchester A.C., Hadley D.M., Will R.G., Colchester A.F. The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease. Lancet 2000, 355:1412-1418.
140. Zerr I., Kallenberg K., Summers D.M., Romero C., Taratuto A., Heinemann U., Breithaupt M., Varges D., Meissner B., Ladogana A., Schuur M., Haik S., Collins S.J., Jansen G.H., Stokin G.B., Pimentel J., Hewer E., Collie D., Smith P., Roberts H., Brandel J.P., van Duijn C., Pocchiari M., Begue C., Cras P., Will R.G., Sanchez-Juan P. Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 2009, 132:2659-2668.